Discogenic non-radicular low back pain: a clinical case report
https://doi.org/10.21518/2079-701X-2020-4-60-65
Abstract
Back pain is often considered under the diagnostic heading “nonspecific pain” because of difficulties in identifying the primary source of pain in everyday clinical practice. However, despite the difficulties in identifying the specific etiology of chronic low back pain, diagnostic procedures can identify its source in 90% of patients. We report a clinical case of typical discogenic pain.
The 6-week pain, which developed after barbell exercising in a 42-year-old man, resulted in the loss of professional employment. The pain was localized to the midline of the lower back (axial pain) and intensified in a sitting position. Computed tomography images demonstrated subchondral changes in L5-S1 vertebral bodies (Modic-1). A holistic diagnostic approach, including a vibration test, made it possible to diagnose the degenerative disc disease (L5-S1 intervertebral disk disease) with subacute discogenic pain. The patient received Dexalgin®25 at a dose of 25 mg x 3 times a day in combination with omeprazole 20 mg per day for 5 days, then the patient was switched to Nimesil 200 mg per day in two divided doses. A complex drug of the SYSADOA group containing glucosamine and chondroitin was used as adjuvant therapy. Pain intensity was reduced by 70 % at 6 weeks (2 points on VAS scale, which corresponds to the level of mild pain syndrome) as compared to the baseline level.
This clinical case stresses the importance of accurate diagnosis of back pain and demonstrates the potential for successful combination non-surgical treatment of discogenic pain in primary outpatient settings.
About the Author
O. V. Vorob’eva
First Moscow State Medical University named after I.M. Sechenov (Sechenov University)
Russian Federation
Russian Federation
Olga V. Vorob’eva - Dr. of Sci. (Med.), Professor, Chair for Nervous Diseases, Institute for Graduate Studies, Federal State Autonomous Educational Institution of Higher Education First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University).
8, p. 2, Trubetskaya St., Moscow, 119991.
References
1. Nijs J., Clark J., MaLfLiet A., Ickmans K., Voogt L., Don S. et al. In the spine or in the brain? Recent advances in pain neuroscience applied in the intervention for Low back pain. Clin Exp Rheumatol. 2017;35(Suppl 107(5)):108-115. Available at: https://www.ncbi.nlm.nih.gov/pubmed/28967357.
2. Dudli S., Fields AJ., Samartzis D., Karppinen J., Lotz J.C. Pathobiology of Modic changes. Eur Spine J. 2016;25(11):3723-3734. doi: 10.1007/s00586-016-4459-7.
3. Yrjama M., Vanharanta H. Bony vibration stimulation: a new, non-invasive method for examining intradiscal pain. Eur Spine J. 1994;3(4):233-235. doi: 10.1007/bf02221600.
4. Boisson M., Lefevre-Colau M., Rannou F., Nguyen Ch. Active discopathy: a clinical reality. RMD Open. 2018;4(1):e000660. doi: 10.1136/rmdopen-2018-000660.
5. Vo N.V., Hartman R.A., Patil P.R., Risbud M.V., Kletsas D., latridis J.C. et al. Molecular mechanisms of biological aging in intervertebral discs. J Orthop Res. 2016;34(8):1289-1306. doi: 10.1002/jor.23195.
6. Huang Z.Y., Xu H.C., Lei T., Li O.L., Wu A.M., Ni W.F. The location of Modic changes in the lumbar spine: a meta-analysis. Eur Spine J. 2016;25(11):3746-3759. doi: 10.1007/s00586-016-4456-x.
7. Nguyen C., Jousse M., Poiraudeau S., Feydy A., Rannou F. Intervertebral disc and vertebral endplate subchondral changes associated with Modic 1 changes of the lumbar spine: a cross-sectional study. BMC Musculoskelet Disord. 2017;18(1):34. doi: 10.1186/s12891-017-1407-6.
8. Johnson Z.I., Schoepflin Z.R., Choi H., Shapiro I.M., Risbud M.V. Disc in flames: Roles of TNF-a and IL-1(3 in intervertebral disc degeneration. Eur Cell Mater. 2015;30:104-117. doi: 10.22203/ecm.v030a08.
9. Anderson D.G., Tannoury C. Molecular pathogenic factors in symptomatic disc degeneration. Spine J. 2005;5(6 Suppl):260-266. doi: 10.1016/j.spinee.2005.02.010.
10. Navone S.E., Marfia G., Canzi L., Ciusani E., Canazza A., Visintini S., Campa-nella R., Parati E.A. Expression of neural and neurotrophic markers in nucleus pulposus cells isolated from degenerated intervertebral disc. J Orthop Res. 2012;30(9):1470-1477. doi: 10.1002/jor.22098.
11. Metscher B., Kubler U., Jahnel-Kracht H. Dexketoprofen-trometamol and tramadol in acute lumbago. Fortschr Med Orig. 2001;118(4):147-151. Available at: https//www.ncbi.nlm.nih.gov/pubmed/11217678.
12. Carne X., Rios J., Torres F. Postmarketing cohort study to assess the safety profile of oral dexketoprofen trometamol for mild to moderate acute pain treatment in primary care. Methods Find Exp Clin Pharmacol. 2009;31(8):533-540. doi: 10.1358/mf.2009.31.8.1419070.
13. Marbet G.A., Yasikoff Strub M.L., Maccioccbi A., Tsakiris D.A. The effect of nimesulide versus placebo on hemostasis in healthy volunteers. Eur J Clin Pharmacol. 1998;54(5):383-387. doi: 10.1007/s002280050479.
14. Rainsford K.D. Members of the Consensus Report Group on Nimesulide. Nimesulide - a multifactorial approach to inflammation and pain: scientific and clinical consensus. Curr Med Res Opin. 2006;22(6):1161-1170. doi: 10.1185/030079906X104849.
15. Soloveva E.Yu., Karneev A.N., Fedin A. I. Dorsopathy: co-use of dexketoprofen and nimesulide during the exacerbation phase. Consilium medicum. 2007;9(2):42-46. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=20307786.
Review
For citations:
Vorob’eva OV. Discogenic non-radicular low back pain: a clinical case report. Meditsinskiy sovet = Medical Council. 2020;(4):60-65. (In Russ.) https://doi.org/10.21518/2079-701X-2020-4-60-65
Views:
804
Email this article 